Individual #00401198

ID_report II:1
Reference PubMed: Panagiotou 2020
Remarks -
Gender F
Consanguinity -
Country China
Population -
Age at death -
VIP -
Data_av -
Treatment right eye: 23-gauge three-port pars plana vitrectomy, internal limiting membrane peeling assisted by membrane dual blue and tamponade with 16% hexafluoroethane (C2F6) gas; posterior subcapsular cataract: surgery with phacoemulsification; intraocular lens
Panel size 1
Diseases USH
Owner name LOVD
Database submission license Creative Commons Attribution 4.0 InternationalCreative Commons License
Created by Anna Tracewska
Date created 2022-01-28 15:03:41 +01:00 (CET)
Date last edited N/A


Phenotypes

Usher syndrome (USH) (USH)   Add phenotype for this disease

AscendingPhenotype ID     

Diagnosis/Initial     

Diagnosis/Definite     

Phenotype details     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000294241 - Usher syndrome type 2A nyctalopia and restricted visual field in both eyes since childhood; diagnosed RP with no family history; bilateral hearing impairment since childhood (hearing aids); best-corrected visual acuity at presentation: 2.5/10 (- 1.00sph) in the RE and 3.5/10 (-1.00cyl 9 90deg) in the left eye (Snellen). Dilated fundoscopy: full-thickness macular hole (FTMH) and posterior vitreous detachment in the right eye; both eyes typical signs of RP including peripheral retinal atrophy with bone spicule-shaped pigmentation in the mid periphery, waxy pallor of the optic nerve head and attenuation of retinal vessels; spectral domain optical coherence tomography confirmed the presence of a FTMH stage IV in the RE along with atrophy of the outer retinal layers and absence of the ellipsoid zone; left eye, thinning of the outer retinal layers was also observed, while the ellipsoid zone was only preserved in the fovea. One month after surgery the successful closure of the macular hole with severe disruption of the ellipsoid zone was confirmed. The scotopic full-field electroretinogram (ffERG): non-recordable in both eyes indicating mostly loss of rod system sensitivity; photopic ERG responses: reduced and delayed in both eyes Familial, autosomal recessive 28y - - - - LOVD



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000402442 DNA SEQ-NG saliva whole exome sequencing USH2A 2 LOVD



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
1 Maternal (confirmed) +/. - pathogenic g.216498841G>T g.216325499G>T USH2A c.949C>A, p.(Arg317=) - USH2A_000155 - PubMed: Panagiotou 2020 - - Germline yes - - - - LOVD USH2A - - - - - NM_206933.2:c.949C>A - r.(?) p.(Arg317=) - - - - - - - - - - - - - -
1 Paternal (confirmed) +/. - pathogenic g.216595579G>A g.216422237G>A USH2A c.100C>T, p.(Arg34Ter) - USH2A_000165 - PubMed: Panagiotou 2020 - - Germline yes - - - - LOVD USH2A - - - - 1 NM_206933.2:c.100C>T - r.(?) p.(Arg34*) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.